• A Case of Argatroban Refractory Heparin Induced Thrombocytopenia and Thrombosis
• A case of non-small cell lung cancer with danazol-dependent aplastic anemia induced by pembrolizumab
• A case of VEXAS syndrome associated with EBV-associated hemophagocytic lymphohistiocytosis
• A clinical, histopathological, and molecular study of two cases of VEXAS syndrome without a definitive myeloid neoplasm
• A gain-of-function variant in the Wiskott-Aldrich syndrome gene is associated with a MYH9-related disease-like syndrome
• A man in his sixties with chondritis and bone marrow failure
• A Novel GATA1 Variant in the C-Terminal Zinc Finger Compared with the Platelet Phenotype of Patients with A Likely Pathogenic Variant in the N-Terminal Zinc Finger
• A novel MBTPS2 variant associated with BRESHECK syndrome impairs sterol-regulated transcription and the endoplasmic reticulum stress response
• A Novel Mutation Leading to Wiskott-Aldrich Syndrome in an Ethiopian Boy: a Case Report and a Review of Literature
• A Novel Splicing Mutation Leading to Wiskott-Aldrich Syndrome from a Family
• A Randomized Controlled Trial Comparing Two Different Schedules for Cisplatin Treatment in Patients with Locoregionally Advanced Nasopharyngeal Cancer
• Abnormal liver function tests and improved survival in a child with splice mutation TARP syndrome
• Accelerated death of megakaryocytes from Wiskott-Aldrich syndrome patients
• Aggregates of nonmuscular myosin IIA in erythrocytes associate with GATA1- and GFI1B-related thrombocytopenia
• Analysis of efficacy and safety of daratumumab-containing regimen in relapsed and refractory multiple myeloma patients
• Apatinib combined with temozolomide in diffuse midline glioma: a novel and effective therapy
• Autoimmunity in Wiskott-Aldrich Syndrome: Updated Perspectives
• Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1
• Break down the barriers of auto-inflammation: How to deal with a monogenic auto-inflammatory disease and immuno-haematological features in 2022?
• Case Report: Haploidentical Bone Marrow Transplantation in Two Brothers With Wiskott-Aldrich Syndrome Using Their Father as the Donor
• Case Report: Non-ossifying fibromas with pathologic fractures in a patient with <em>NONO</em>-associated X-linked syndromic intellectual developmental disorder
• Case Report: Non-ossifying fibromas with pathologic fractures in a patient with NONO-associated X-linked syndromic intellectual developmental disorder
• Case Report: PD-1 Inhibitor Is Active in Lung Adenocarcinoma With B Cell Deficiency
• Case Report: Wiskott-Aldrich Syndrome Caused by Extremely Skewed X-Chromosome Inactivation in a Chinese Girl
• Case report: XMEN disease: a patient with recurrent Hodgkin lymphoma and immune thrombocytopenia
• Chronic immune thrombocytopenia in a child with X-linked agammaglobulinemia-an uncommon phenotype
• Circulating bioactive bacterial DNA is associated with immune activation and complications in common variable immunodeficiency
• Clinical and genetic analysis of 2 rare cases of Wiskott-Aldrich syndrome from Chinese minorities: Two case reports
• Clinical and molecular characteristics of Wiskott-Aldrich Syndrome in five unrelated Chinese families
• Clinical characteristics and prognosis of patients with anti-glutamic acid decarboxylase antibody-related cerebellar ataxia
• Clinical Features, Cancer Biology, Transplant Approach and Other Integrated Management Strategies for Wiskott-Aldrich Syndrome
• Clinical Heterogeneity of the VEXAS Syndrome: A Case Series
• Clinical profile of hospitalised moderate category COVID-19 patients: Short study from a Tertiary Care Centre in Delhi
• Clinical, Laboratory Features and Clinical Courses of Patients with Wiskott Aldrich Syndrome and X-linked Thrombocytopenia-A single center study
• Coagulopathy induced by viperid snake venoms in a murine model: Comparison of standard coagulation tests and rotational thromboelastometry
• Comparing effectiveness and safety of paclitaxel plus raltitrexed <em>vs.</em> paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
• Comparing effectiveness and safety of paclitaxel plus raltitrexed vs. paclitaxel alone in second-line palliative chemotherapy for metastatic gastric adenocarcinoma: A randomized phase II clinical trial
• Confirmed diagnosis of classic Wiskott-Aldrich syndrome in East Africa: a case report
• CRISPR/Cas9-mediated gene editing. A promising strategy in hematological disorders
• Cutaneous involvement in VEXAS syndrome: clinical and histopathologic findings
• Cytopenia: a report of haplo-cord transplantation in twin brothers caused by a novel germline GATA1 mutation and family survey
• Development of a rabbit model of Wiskott-Aldrich syndrome
• Effects of Apatinib Mesylate Monotherapy on the Incidence of Adverse Reactions and Immune Function in Patients with Breast Cancer after Radical Mastectomy
• Efficacy and tolerability of quinidine as salvage therapy for monomorphic ventricular tachycardia in patients with structural heart disease
• Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population
• First reported co-occurrence of "GATA1-mutated X-linked thrombocytopenia with thalassemia (XLTT)" with heterozygous beta-thalassemia
• First reported co-occurrence of "GATA1-mutated X-linked thrombocytopenia with thalassemia (XLTT)" with heterozygous β-thalassemia
• Frontier and hotspot evolution in Wiskott-Aldrich syndrome: A bibliometric analysis from 2001 to 2021
• Gastrointestinal Manifestations in Systemic Lupus Erythematosus: Data from an Indian Multi-institutional Inception (INSPIRE) Cohort
• Genetic analysis of a Fanconi anemia case revealed the presence of FANCF mutation (exon 1;469&gt;C-T) with implications to develop acute myeloid leukemia
• Genetic Profiling of Idiopathic Antenatal Intracranial Haemorrhage: What We Know?
• Haploidentical bone marrow transplantation in a pediatric patient with Wiskott-Aldrich syndrome. A case report
• Hematopoietic Stem Cell Therapy for Wiskott-Aldrich Syndrome: Improved Outcome and Quality of Life
• Improvement in platelet count and bleeding symptom during treatment with eltrombopag in a patient with X-linked thrombocytopenia
• Influenza-associated thrombotic thrombocytopenic purpura: A report of two cases and a brief review of the literature
• Mediastinal lymphadenopathy due to VEXAS syndrome
• Membranous nephropathy in a female patient with X-linked thrombocytopenia
• Mild thrombocytopenia indicating maternal organ damage in pre-eclampsia: a cross-sectional study
• Myelin oligodendrocyte glycoprotein antibody-associated disease as a novel presentation of central nervous system autoimmunity in a pediatric patient with Wiskott-Aldrich syndrome
• Neoadjuvant Chemoimmunotherapy for the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma: A Single-Arm Phase 2 Clinical Trial
• Nodular regenerative hyperplasia in X-linked agammaglobulinemia: An underestimated and severe complication
• Not too little, not too much: the impact of mutation types in Wiskott-Aldrich syndrome and RAC2 patients
• Novel <em>MAGT1</em> Mutation Found in the First Chinese XMEN in Hong Kong
• Onasemnogene abeparvovec gene replacement therapy for the treatment of spinal muscular atrophy: a real-world observational study
• Phase 2 Study of Adjuvant Radiotherapy Following Narrow-Margin Hepatectomy in Patients With HCC
• Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis
• Phase I Study and Cell-Free DNA Analysis of T-DM1 and Metronomic Temozolomide for Secondary Prevention of HER2-Positive Breast Cancer Brain Metastases
• Phenotypic manifestations in <em>FLNA</em>-related periventricular nodular heterotopia: a case report and review of the literature
• Platelet function and filamin A expression in two families with novel FLNA gene mutations associated with periventricular nodular heterotopia and panlobular emphysema
• Post-neoadjuvant chemoradiotherapy tumor resectability following induction chemotherapy in locally advanced proximal gastric and adenocarcinoma of the esophagogastric junction: A clinical trial
• Potential Pro-Inflammatory Effect of Vitamin E Analogs through Mitigation of Tetrahydrocannabinol (THC) Binding to the Cannabinoid 2 Receptor
• Rare solid tumors in a patient with Wiskott-Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature
• Relative Dose Intensity of Chemotherapy and Survival in Patients with Advanced Stage Solid Tumor Cancer: A Systematic Review and Meta-Analysis
• Report of clinical presentations and two novel mutations in patients with Wiskott-Aldrich syndrome/X-linked Thrombocytopenia
• Rituximab, Omalizumab, and Dupilumab Treatment Outcomes in Bullous Pemphigoid: A Systematic Review
• Safety and efficacy of induction immunochemotherapy with rituximab, methotrexate, ifosfamide, and vincristine (R-MIV) in patients with primary CNS lymphoma including recent COVID-19 pandemic experience
• Safety and efficacy of irinotecan, oxaliplatin, and capecitabine (XELOXIRI) regimen with or without targeted drugs in patients with metastatic colorectal cancer: a retrospective cohort study
• Safety and pharmacokinetics of thalidomide in tumor-bearing dogs
• Selective Btk inhibition by PRN1008/PRN473 blocks human CLEC-2 &amp; PRN473 reduces venous thrombosis formation in mice
• Severe antenatal intraventricular hemorrhage in a newborn with WASP pathogenic variant
• Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS
• Spectrum of clonal hematopoiesis in VEXAS syndrome
• Successful surgical repair of critical ascending and descending aortic aneurysms at nine-year intervals in Wiskott-Aldrich syndrome: A case report
• Talazoparib, a Poly(ADP-ribose) Polymerase Inhibitor, for Metastatic Castration-resistant Prostate Cancer and DNA Damage Response Alterations: TALAPRO-1 Safety Analyses
• The Clinical and Laboratory Characteristics of Adult Langerhans Cell Histiocytosis Patients and the Influencing Factors of Prognosis
• The Wiskott-Aldrich syndrome protein is required for positive selection during T-cell lineage differentiation
• Twin Premature Infants With Riboflavin and Biotin Deficiency Presenting With Refractory Lactic Acidosis, Rash, and Multiorgan Failure During Prolonged Parenteral Nutrition
• Utility of Platelet Indices as a Predictive Marker in Sepsis: An Observational Study From North East India
• Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report
• VEXAS syndrome with severe multisystem involvement: Rapid recovery after splenectomy
• VEXAS syndrome: An update
• VEXAS syndrome: Clinical, hematologic features and a practical approach to diagnosis and management
• Wiskott Aldrich Syndrome: A Multi-Institutional Experience From India
• Wiskott-Aldrich Syndrome
• Wiskott-Aldrich Syndrome
• Wiskott-Aldrich syndrome with normal platelet volume in a low-income setting: a case report
• Wiskott-Aldrich syndrome with platelets of normal size and c.295C&gt;T mutation of the WAS gene. Case report
• Wiskott-Aldrich syndrome with possible congenital <em>Cytomegalovirus</em> infection: A diagnostic dilemma
• Wiskott-Aldrich syndrome: Oral findings and microbiota in children and review of the literature
• X-linked C1GALT1C1 mutation causes atypical hemolytic uremic syndrome